A phase I study of E7080, a multitargeted tyrosine kinase inhibitor, in patients with advanced solid tumours
2012
A phase I study of E7080, a multitargeted tyrosine kinase inhibitor, in patients with advanced solid tumours
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
37
References
127
Citations
NaN
KQI